These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 10531567)

  • 1. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
    Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
    Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
    J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical indications for Ewing's sarcoma of the pelvis.
    Yang RS; Eckardt JJ; Eilber FR; Rosen G; Forscher CA; Dorey FJ; Kelly CM; al-Shaikh R
    Cancer; 1995 Oct; 76(8):1388-97. PubMed ID: 8620413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma.
    Paulino AC; Nguyen TX; Mai WY
    Pediatr Blood Cancer; 2007 Apr; 48(4):423-9. PubMed ID: 16421909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of surgery with radiation on pelvic Ewing sarcoma survival.
    Ng VY; Jones R; Bompadre V; Louie P; Punt S; Conrad EU
    J Surg Oncol; 2015 Dec; 112(8):861-5. PubMed ID: 26525492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group.
    Daw NC; Laack NN; McIlvaine EJ; Krailo M; Womer RB; Granowetter L; Grier HE; Marina NM; Bernstein ML; Gebhardt MC; Marcus KJ; Advani SM; Healey JH; Letson GD; Gorlick RG; Randall RL
    Ann Surg Oncol; 2016 Oct; 23(11):3541-3547. PubMed ID: 27216741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal Treatment in Pelvic Ewing Sarcoma: A Prognostic Factor Analysis.
    Muratori F; Totti F; Cuomo P; Beltrami G; Matera D; Tamburrini A; Capanna R; Roselli G; Campanacci DA
    Surg Technol Int; 2019 May; 34():489-496. PubMed ID: 30888673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and Outcome of Ewing Sarcoma of the Head and Neck.
    Grevener K; Haveman LM; Ranft A; van den Berg H; Jung S; Ladenstein R; Klco-Brosius S; Juergens H; Merks JH; Dirksen U
    Pediatr Blood Cancer; 2016 Apr; 63(4):604-10. PubMed ID: 26702872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis.
    Bacci G; Ferrari S; Mercuri M; Longhi A; Giacomini S; Forni C; Bertoni F; Manfrini M; Barbieri E; Lari S; Donati D
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):118-24. PubMed ID: 12571462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
    Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
    Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
    Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
    Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
    Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment for pelvic Ewing sarcoma: What is a safe and functional acetabular reconstruction when combined with modern multidisciplinary treatments?
    Fujiwara T; Lex JR; Stevenson JD; Tsuda Y; Clark R; Parry MC; Grimer RJ; Jeys LM
    J Surg Oncol; 2019 Nov; 120(6):985-993. PubMed ID: 31381161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.